These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 19476476)

  • 1. Pioglitazone decreases postprandial accumulation of remnant lipoproteins in insulin-resistant smokers.
    Abbasi F; Lamendola C; Leary ET; Reaven GM
    Diabetes Obes Metab; 2009 Aug; 11(8):779-85. PubMed ID: 19476476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers.
    Abbasi F; Farin HM; Lamendola C; McGraw L; McLaughlin T; Reaven GM
    Metabolism; 2008 Aug; 57(8):1108-14. PubMed ID: 18640389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of pioglitazone on fasting and postprandial levels of lipid and hemostatic variables in overweight non-diabetic patients with coronary artery disease.
    Mieszczanska H; Kaba NK; Francis CW; Gerich JE; Dodis R; Schwarz KQ; Phipps RP; Smith BH; Lee M; Messing S; Taubman MB
    J Thromb Haemost; 2007 May; 5(5):942-9. PubMed ID: 17461928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of metformin and rosiglitazone on postprandial lipid metabolism in obese insulin-resistant subjects.
    James AP; Watts GF; Mamo JC
    Diabetes Obes Metab; 2005 Jul; 7(4):381-9. PubMed ID: 15955124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exacerbation of insulin resistance and postprandial triglyceride response in newly diagnosed hypertensive patients with hypertriglyceridaemia.
    Hwu CM; Kwok CF; Kuo CS; Hsiao LC; Lee YS; Wei MJ; Kao WY; Lee SH; Ho LT
    J Hum Hypertens; 2002 Jul; 16(7):487-93. PubMed ID: 12080433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pioglitazone on lipid and lipoprotein metabolism.
    Betteridge DJ
    Diabetes Obes Metab; 2007 Sep; 9(5):640-7. PubMed ID: 17697057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.
    Stalenhoef AF; de Graaf J
    Curr Opin Lipidol; 2008 Aug; 19(4):355-61. PubMed ID: 18607182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
    Miyazaki Y; DeFronzo RA
    Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained effects of pioglitazone vs. glibenclamide on insulin sensitivity, glycaemic control, and lipid profiles in patients with Type 2 diabetes.
    Tan MH; Johns D; Strand J; Halse J; Madsbad S; Eriksson JW; Clausen J; Konkoy CS; Herz M;
    Diabet Med; 2004 Aug; 21(8):859-66. PubMed ID: 15270789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association of different measures of insulinaemia with vascular risk factors in healthy normoglycaemic normotensive non-obese men and women.
    Winocour PH; Kaluvya S; Brown L; Farrer M; Millar JP; Neil H; Alberti KG
    Q J Med; 1991 Jun; 79(290):539-60. PubMed ID: 1946934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between insulin resistance and dyslipidaemia in cigarette smokers.
    Farin HM; Abbasi F; Kim SH; Lamendola C; McLaughlin T; Reaven GM
    Diabetes Obes Metab; 2007 Jan; 9(1):65-9. PubMed ID: 17199720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of pioglitazone and metformin on insulin resistance and hormonal markers in patients with impaired glucose tolerance and early diabetes.
    Eguchi K; Tomizawa H; Ishikawa J; Hoshide S; Numao T; Fukuda T; Shimada K; Kario K
    Hypertens Res; 2007 Jan; 30(1):23-30. PubMed ID: 17460368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone.
    Abbasi F; Lima NK; Reaven GM
    Metabolism; 2009 Mar; 58(3):373-8. PubMed ID: 19217454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
    Reaven GM
    Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of pioglitazone in type 2 diabetes: a randomised, placebo-controlled study in patients receiving stable insulin therapy.
    Rosenstock J; Einhorn D; Hershon K; Glazer NB; Yu S;
    Int J Clin Pract; 2002 May; 56(4):251-7. PubMed ID: 12074206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
    Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
    Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced postprandial proinsulinaemia and 32-33 split proinsulinaemia after a mixed meal in type 2 diabetic patients following sensitization to insulin with pioglitazone.
    Cooper MB; Al Majali K; Bailey CJ; Betteridge DJ
    Clin Endocrinol (Oxf); 2008 May; 68(5):738-46. PubMed ID: 17980009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of pioglitazone and metformin on plasma adiponectin in newly detected type 2 diabetes mellitus.
    Sharma PK; Bhansali A; Sialy R; Malhotra S; Pandhi P
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):722-8. PubMed ID: 17121522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
    Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
    Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone and mechanisms of CV protection.
    Erdmann E; Wilcox R
    QJM; 2010 Apr; 103(4):213-28. PubMed ID: 19955228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.